Gaboy stated: " IMO, Biocurex has the same potential as similar Biotech companies if the right milestones are met."
RPC was hyped by BioMed back in April and the latest surge was also initiated by a hype from BioMed with blow by blow hype continuted by BioMed on twitter. It was very effective hype.
The problem is the product. Just like RECAF, Onko Sure will not have any significant medical use.
Buger has stated all of his lofty goals but reality will prove them to be just dreams. The problem for investors is that nothing more has to be filed with the SEC for over 3 months. Wait and see. March 31 will roll around with no third licensee signed, No POC test developed, No sales of Dog RECAF and No additional progress by Abbott or Alere.
GoldSeekerâ„¢
I have never shorted nor intend to have any financial interest in BOCX. I am not connected with anyone who trades, shorts or has financial interests in BOCX. I only post facts and my opinions. I do not post on IHUB with different aliases.